Development of specification for substance 7-azepan-1- il-1-ethil-6-ftor-3- (4-phenyl-1, 3-tiazol-2-il) - Quinoline- 4 (1h)-one

dc.contributor.authorSpyrydonova, N.
dc.contributor.authorSilin, A.
dc.contributor.authorLebedynets, Vyacheslav
dc.contributor.authorZavada, O.
dc.contributor.authorKalinenko, Olga
dc.date.accessioned2019-05-06T09:29:57Z
dc.date.available2019-05-06T09:29:57Z
dc.date.issued2019-05
dc.description.abstractThe paper presents the results of the development of specifications for a new first-synthesized chemical compound exhibiting antibacterial activity and positioned as a perspective drug substance. According to the recommendations of the European Pharmacopoeia quality control procedures have been developed for standardization the substance of 7-azepan-1-yl-1-ethyl-6-fluoro-3-(4-phenyl-1,3-thiazol-2-yl))- quinoline-4(1H)-one - a modified derivative of the fluoroquinolone series.ru_RU
dc.identifier.citationDevelopment of specification for substance 7-azepan-1- il-1-ethil-6-ftor-3- (4-phenyl-1, 3-tiazol-2-il) - Quinoline- 4 (1h)-one / N. V. Spyrydonova, A. V. Silin, V. A. Lebedynets, O. A. Zavada, O. S. Kalinenko // The Pharma Innovation Journal. – 2019. – V. 8 (5). – P. 54–56.ru_RU
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/22757
dc.language.isoenru_RU
dc.subjectquality control methodru_RU
dc.subjectspecificationru_RU
dc.subjectactive pharmaceutical ingredientru_RU
dc.subjectquinoloneru_RU
dc.subjectantibacterial agentru_RU
dc.titleDevelopment of specification for substance 7-azepan-1- il-1-ethil-6-ftor-3- (4-phenyl-1, 3-tiazol-2-il) - Quinoline- 4 (1h)-oneru_RU
dc.typeArticleru_RU

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Development of specification for substance.pdf
Size:
541.88 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
11.51 KB
Format:
Item-specific license agreed upon to submission
Description: